Literature DB >> 16527862

Nitric oxide synthase 2 and pressure-overload-induced left ventricular remodelling in mice.

Ryuji Hataishi1, Ana Clara Rodrigues, John G Morgan, Fumito Ichinose, Geneviève Derumeaux, Kenneth D Bloch, Michael H Picard, Marielle Scherrer-Crosbie.   

Abstract

Nitric oxide synthase 2 (NOS2) has been reported to increase in hypertrophied cardiomyocytes; however, whether NOS2 plays a role in the development of hypertrophy is unknown. To investigate the relationship of NOS2 with left ventricular (LV) remodelling and hypertrophy following prolonged pressure overload, we studied 18 male wild-type (WT) and 20 male NOS2-deficient (NOS2-/-) mice before and 7, 14 and 28 days after transverse aortic constriction (TAC) using echocardiography. A subgroup of eight WT and eight NOS2-/- mice were studied 42 days after TAC. Haemodynamic measurements were obtained before killing. Left ventricular size and function were similar for both genotypes at baseline. After TAC for 28 days, both groups developed LV hypertrophy, with echo-derived LV mass increasing from 78 +/- 2 to 147 +/- 10 mg in WT and from 86 +/- 3 to 142 +/- 10 mg in NOS2-/- mice. Twenty-eight days after TAC, LV weight and cardiomyocyte width were also similar in both genotypes. Fractional shortening (FS) decreased on day 7 from 57 +/- 1 to 48 +/- 2% in WT and from 59 +/- 1 to 49 +/- 2% in NOS2-/- mice. Although this decrease in FS was transient in WT mice, it persisted in NOS2-/- mice. Invasively measured parameters of systolic and diastolic function, however, were similar in the two genotypes both 28 and 42 days after TAC. A load-independent index of contractility, Emax, was similar in both strains 42 days after TAC. In conclusion, NOS2 does not appear to have a critical role in the development of LV hypertrophy after chronic pressure overload.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527862     DOI: 10.1113/expphysiol.2005.033068

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  5 in total

Review 1.  Relevance of nitric oxide for myocardial remodeling.

Authors:  Paul B Massion; Jean-Luc Balligand
Journal:  Curr Heart Fail Rep       Date:  2007-03

2.  Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury.

Authors:  Yiru Guo; Santosh K Sanganalmath; Wenjian Wu; Xiaoping Zhu; Yiming Huang; Wei Tan; Suzanne T Ildstad; Qianhong Li; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2012-02-21       Impact factor: 17.165

Review 3.  Ventricular remodeling and function: insights using murine echocardiography.

Authors:  Marielle Scherrer-Crosbie; Baptiste Kurtz
Journal:  J Mol Cell Cardiol       Date:  2009-07-15       Impact factor: 5.000

4.  Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling.

Authors:  Manling Zhang; Eiki Takimoto; Dong-ik Lee; Celio X C Santos; Taishi Nakamura; Steven Hsu; Aiyang Jiang; Takahiro Nagayama; Djahida Bedja; Yuan Yuan; Philip Eaton; Ajay M Shah; David A Kass
Journal:  Circulation       Date:  2012-07-24       Impact factor: 29.690

Review 5.  Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review).

Authors:  Adriana V Treuer; Daniel R Gonzalez
Journal:  Mol Med Rep       Date:  2014-11-18       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.